Skip to main content
Log in

Primary hypertension at a single center: treatment, time to control, and extended follow-up

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

We present data on presentation, treatment, and follow-up of 65 pediatric patients with primary hypertension treated over the past 12 years, including initial anthropometric data, pharmacologic treatment, time to control for both systolic and diastolic blood pressure (SBP/DBP), and maintenance of control over time. Data was normalized to standard deviation scores (SDS) for mathematical analysis, and antihypertensive medication dosages were converted to dosage equivalents for a single member of each antihypertensive class. We used multiple regression analysis and Kaplan-Meier survival curves to determine the time to control, medication, and dose effectiveness. Patients were seen for an average of seven visits over 25 months. Initial BPs averaged 134/71 mmHg (2.1/0.6 SDS). Patients were taller, heavier, and had higher body mass index than average for age and sex. By the fourth visit, SBP was <90th percentile in 79%. Ninety percent could be controlled, although 32 lost control at some point (at least 16 due to noncompliance). At the last visit, 46 were controlled, and 5/8 patients off medication remained normotensive. Only angiotensin-converting enzyme inhibitors and β-blockers demonstrated significant association with BP control. This is the first study to document the time to control of BP, and it can serve as an initial standard for quality assessment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chiolero A, Cachat F, Burnier M, Paccaud F, Bovet P (2007) Prevalence of hypertension in schoolchildren based on repeated measurements and association with overweight. J Hypertens 25:2209–2217

    Article  CAS  Google Scholar 

  2. Din-Dzietham R, Liu Y, Bielo M-V, Shamsa F (2007) High blood pressure trends in children and adolescents in National surveys, 1963 to 2002. Circulation 116:1488–1496

    Article  Google Scholar 

  3. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ (2004) Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 113:475–482

    Article  Google Scholar 

  4. Bartosh S, Aronson A (1999) Childhood hypertension: an update on etiology, diagnosis, and treatment. Pediatr Clin North Am 46:235–252

    Article  CAS  Google Scholar 

  5. Hansen ML, Gunn PW, Kaelber DC (2007) Underdiagnosis of hypertension in children and adolescents. JAMA 298:874–879

    Article  CAS  Google Scholar 

  6. Robinson R, Batisky D, Hayes J, Nahata M, Mahan J (2004) Body mass index in primary and secondary pediatric hypertension. Pediatr Nephrol 19:1379–1384

    Article  Google Scholar 

  7. Flynn J, Falkner B (2008) Children and adolescents with obesity-associated high blood pressure. J Am Soc Hypertens 2:267–274

    Article  Google Scholar 

  8. Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N (2005) Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 45:602–607

    Article  CAS  Google Scholar 

  9. Freedman D, Dietz W, Srinivasan S, Berensen G (1999) The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa heart study. Pediatrics 103:1175–1182

    Article  CAS  Google Scholar 

  10. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004). The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:1−22

    Article  Google Scholar 

  11. Zemel MB (1997) Dietary pattern and hypertension: the DASH study. Dietary approaches to stop hypertension. Nutr Rev 55:303–305

    Article  CAS  Google Scholar 

  12. Wells T, Stowe C (2001) An approach to the use of antihypertensive drugs in children and adolescents. Curr Ther Res Clin E 62:329–350

    Article  CAS  Google Scholar 

  13. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC Growth Charts: United States. Adv Data 1−27

  14. Bailey KR, Grossardt BR, Graves JW (2008) Novel use of Kaplan-Meier methods to explain age and gender differences in hypertension control rates. Hypertension 51:841–847

    Article  CAS  Google Scholar 

  15. Physician’s Desk Reference (2008) 62 ed. 2008, Montvale Thompson Healthcare Inc

  16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, The National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206–1252

    Article  CAS  Google Scholar 

  17. Sieber US, von Vigier RO, Sforzini C, Fossali E, Edefonti A, Bianchetti MG (2003) How good is blood pressure control among treated hypertensive children and adolescents? J Hypertens 21:633–637

    Article  CAS  Google Scholar 

  18. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497

    Article  CAS  Google Scholar 

  19. Michaud P, Suris J, Viner R (2004) The adolescent with a chronic condition. Part II: healthcare provision. Arch Dis Child 89:943–949

    Article  Google Scholar 

  20. Winnick S, Lucas D, Hartman A, Toll D (2005) How do you improve compliance? Pediatrics 115:718–724

    Article  Google Scholar 

  21. Rianthavorn P, Ettenger R (2005) Medication non-adherence in the adolescent renal transplant recipient: a clinician's viewpoint. Pediatr Transplant 9:398–407

    Article  CAS  Google Scholar 

  22. Woroniecki R, Flynn J (2005) How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologist. Pediatr Nephrol 20:791–797

    Article  Google Scholar 

  23. Flynn J, Daniels S (2006) Pharmacologic treatment of hypertension in children and adolescents. J Pediatr 149:746–754

    Article  CAS  Google Scholar 

  24. Paradis G, Lambert M, O'Loughlin J, Lavallee C, Aubin J, Delvin E, Levy E, Hanley JA (2004) Blood pressure and adiposity in children and adolescents. Circulation 110:1832–1838

    Article  Google Scholar 

  25. Israeli E, Schochat T, Korzets Z, Tekes-Manova D, Bernheim J, Golan E (2006) Prehypertension and obesity in adolescents: a population study. Am J Hypertens 19:708–712

    Article  Google Scholar 

  26. Koulouridis E, Georgalidis K, Kostimpa I, Kalantzi M, Ntouto P, Koulouridis I, Mandyla M, Krokida A, Boulgari N (2008) Factors influencing blood pressure control in children and adolescents. Int Urol Nephrol 40:741–748

    Article  CAS  Google Scholar 

  27. Podoll A, Grenier M, Croix B, Feig DI (2007) Inaccuracy in pediatric outpatient blood pressure measurement. Pediatrics 119:e538–e543

    Article  Google Scholar 

  28. Swartz SJ, Srivaths PR, Croix B, Feig DI (2008) Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children. Pediatrics 122:1177–1181

    Article  Google Scholar 

  29. Sorof JM, Portman RJ (2000) Ambulatory blood pressure monitoring in the pediatric patient. J Pediatr 136:578–586

    Article  CAS  Google Scholar 

  30. Gavrilovici C, Goldsmith DJ, Reid C, Gubeth-Tatomir P, Covic A (2004) What is the role of ambulatory BP monitoring in pediatric nephrology? J Nephrol 17:642–652

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven Joel Wassner.

Appendix

Appendix

Calculation of antihypertensive dosage equivalents

Medication class

Base medication

Medication administered

× Conversion factor

Angiotensin-converting enzyme inhibitors (ACEI)

Enalapril equivalents

Enalapril

1

Lisinopril

1

Fosinopril or quinapril or benazepril

0.5

Ramipril

2

β-blockers

Propranolol

Propranolol

1

Atenolol

6.4

Metoprolol

1.42

Calcium-channel inhibitors

Amlodipine

Amlodipine

1

Nifedipine

0.055

Thiazide diuretics

Hydrochlorothiazide

Hydrochlorothiazide

1

Chlorothiazide

0.1

Angiotensin receptor blockers

Valsartan

Valsartan

1

Losartan

3.2

Olmesartan

8

  1. Example: a child received a dose of 20 mg of ramipril, which is equivalent to a dose of 40 mg of enalapril (20× conversion factor of 2 = 40)

Rights and permissions

Reprints and permissions

About this article

Cite this article

DiPietro, A., Kees-Folts, D., DesHarnais, S. et al. Primary hypertension at a single center: treatment, time to control, and extended follow-up. Pediatr Nephrol 24, 2421–2428 (2009). https://doi.org/10.1007/s00467-009-1297-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-009-1297-4

Keywords

Navigation